Earnings History Data for Galectin Therapeutics Inc. (GALT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Galectin Therapeutics Inc.

Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
17-05-2021 PM GALT Galectin Therapeutics Inc. 240.63 -0.11 -0.17 -0.06 Galectin Therapeutics EPS beats by $0.06
[5/17/2021 8:34 AM]
4.35 0.12 
4.13 -0.10 
1.82 - 5.70 873,744 1,070,000 3,437
31-03-2021 PM GALT Galectin Therapeutics Inc. 118.00 -0.14 -0.16 0.00 Galectin Therapeutics EPS beats by $0.02
[3/31/2021 8:42 AM]
2.19 0.16 
2.09 0.06 
1.65 - 3.85 220,019 190,000 1,499
09-11-2020 PM GALT Galectin Therapeutics Inc. 147.83 -0.10 -0.14 -0.05 Galectin Therapeutics reports Q3 results
[11/9/2020 8:18 AM]
2.79 0.10 
2.52 0.0 
1.50 - 4.50 199,303 156,603 895